CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN 1 M146L mutation
CRISPR-Cas9 治疗可部分恢复携带阿尔茨海默病 PSEN 1 M146L 突变的人类成纤维细胞中的淀粉样蛋白 β42/40。
期刊:Molecular Therapy-Nucleic Acids
影响因子:6.5
doi:10.1016/j.omtn.2022.03.022
Evangelos Konstantinidis ,Agnieszka Molisak ,Florian Perrin ,Linn Streubel-Gallasch ,Sarah Fayad ,Daniel Y Kim ,Karl Petri ,Martin J Aryee ,Ximena Aguilar ,Bence György ,Vilmantas Giedraitis ,J Keith Joung ,Vikram Pattanayak ,Magnus Essand ,Anna Erlandsson ,Oksana Berezovska ,Martin Ingelsson